news roundup
eClinicalHealth and Clinerion have collaborated to offer their two clinical trial platforms in tandem to hospitals and sponsor companies/CROs.
advertisment
Transforming Patient Recruitment through Patient and Site Engagement
Live Webinar: Tuesday, August 23, 2016 at 11 am – 12 noon EDT
Register now
|
The newly accredited organizations are the first in South America, Africa and New Jersey as well as in Brazil.
SCORR Marketing and Applied Clinical Trials latest survey of trial project managers offers sponsors and CROs insight on how to improve relations with project management teams.
|
|
|
advertisment
The State of Risk-based Monitoring (RBM)
ON Demand
Learn now
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Articles
Focusing on the core BRIC (Brazil, Russia, India and China) markets, this article highlights some of the key challenges in conducting clinical trials in emerging markets.
By relying on electronic processes, many argue that virtually conducted clinical trials offer opportunities for a more patient-centered approach.
|
|
Blog Posts
This article reports the outcome of events Quintiles hosted to encourage collaboration to address recruiting challenges during Clinical Trials Awareness Week. The ideas and best practices of patient advocates, congressional staff and researchers are shared.
This article discusses the challenges affecting outsourcing functions to measure vendor performance, explores new ways of measuring performance, and investigates how novel eClinical technologies enlarge the quantification of vendor performance measurement metrics.
|
|
Oncology
The objective of this new era of precision medicine coupled with advancing technologies is enabling new trial designs that match patients to the right genomic- or immune-targeted drugs.
US Oncology Research integrates community-based oncology practices into a physician-led network of over 900 investigators, and has joined SCRS to help industry make improvements in oncology clinical trial execution.
WCCT Global's acquisition of Medelis, an oncology clinical research organization, will offer clients greater access to oncology and immuno-oncology research services worldwide.
This article examines four drug safety experts, who were not medical oncologists, but had experience monitoring oncology trials independently, and analyzed their agreements in NSCLC trials.
|
|
|
|
Read the digital edition of Applied Clinical Trials Click here to sign up or renew your subscription
|
|
|
|
|